Kim Kwan is the Chief Technology Officer at Cognito Therapeutics. Kim is responsible for overseeing the technical strategy, device development and manufacturing operations to support the company’s clinical studies and product commercialization. His focus is to build a system platform that is scalable and can support treatment for a broad range of neurodegenerative diseases starting with Alzheimer’s Disease. He is an engineer by trade and at heart with close to three decades of Class III, Class II, PMA, IDE, and 510K medical device experience in startup, midsize and Fortune 500 companies with varied technical and leadership roles. In his spare time, he enjoys road tripping with his family and tinkering with electronics such as Ham radios, pinball machines, home automation devices, and more. Kim received his BS in Electrical Engineering from Northeastern University.
